Respiratory imaging group 4DMedical secures $150m backing from institutions as US rollout ramps up

Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) has raised $150 million from institutional investors to accelerate commercialisation of its key CT:VQ product in the US where it has already been deployed to four major health operators.

The placement has been announced in tandem…


Click here to view the original article.